Notably, combined silencing of ZDHHC1 and LIPG diminished the proliferative effects of ZDHHC1 downregulation in vitro and in vivo (Fig. 4A–K), indicating that ZDHHC1 inhibits CRC progression by targeting LIPG for down-regulation. Here, ZDHHC1 is linked to colorectal carcinoma.